Anatumomab mafenatox

From Wikipedia, the free encyclopedia

Anatumomab mafenatox ^?

Monoclonal antibody
Source	mouse
Target	glycoprotein 72
Identifiers
CAS number	?
ATC code	none
PubChem	?
Chemical data
Formula	?
Mol. mass	?
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Anatumomab mafenatox is a mouse monoclonal antibody which is used to treat non-small cell lung cancer.^[1]

It is a fusion protein with an enterotoxin ('mafenatox') of Staphylococcus aureus.^[2]

[edit] References

v • d • e Mouse monoclonal antibodies ("-o-") "-govo-" (ovarian tumor) Abagovomab, Igovomab, Oregovomab "-limo-" (immune system) Afelimomab, Elsilimomab, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox "-tumo-" (miscellaneous tumor) Altumomab pentetate, Anatumomab mafenatox, Arcitumomab, Bectumomab, Blinatumomab, Detumomab, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab pendetide, Taplitumomab paptox, Tenatumomab, Tositumomab, 3F8 "-leso-" (infectious lesions) Besilesomab, Fanolesomab§, Lemalesomab, Sulesomab "-ciro-" (cardiovascular) Biciromab§, Imciromab§ "-pro-" (prostate tumor) Capromab pendetide "-baco-" (bacterial) Edobacomab "-colo-" (colonic tumor) Edrecolomab, Nacolomab tafenatox §Withdrawn

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. v • d • e